| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.34 | 1e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-10 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-05 |